Literature DB >> 10454257

Anti-metastatic activity of curcumin and catechin.

L G Menon1, R Kuttan, G Kuttan.   

Abstract

The inhibitory effects of curcumin and catechin on lung metastasis induced by B16F-10 melanoma cells were studied in female C57BL/6 mice. Curcumin and catechin significantly (P < 0.001) inhibited lung tumour formation (89.3% and 82.2%, respectively) and significantly increased the life span (143.9% and 80.8%, respectively). Moreover, lung collagen hydroxyproline and serum sialic acid levels were found to be significantly (P < 0.001) lower in treated animals compared to the untreated controls. Curcumin and catechin treatment (10 microg/ml) significantly inhibited the invasion of B16F-10 melanoma cells across the collagen matrix of the Boyden chamber. Gelatin zymographic analysis of the trypsin-activated B16F-10 melanoma cells sonicate revealed that curcumin- and catechin-treated zymograms did not show any metalloproteinase activity. Curcumin and catechin treatment did not inhibit the motility of B16F-10 melanoma cells across a polycarbonate filter in vitro. These findings suggest that curcumin and catechin inhibit the invasion of B16F-10 melanoma cells by inhibition of metalloproteinases, thereby inhibiting lung metastasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454257     DOI: 10.1016/s0304-3835(99)00098-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

1.  Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice.

Authors:  C R Pradeep; G Kuttan
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Curcumin regulates hepatoma cell proliferation and apoptosis through the Notch signaling pathway.

Authors:  Zheng-Cai Liu; Zhao-Xu Yang; Jing-Shi Zhou; Hong-Tao Zhang; Qi-Ke Huang; Li-Li Dang; Guang-Xin Liu; Kai-Shan Tao
Journal:  Int J Clin Exp Med       Date:  2014-03-15

3.  Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network.

Authors:  Mohammad Amin Mahjoub; Babak Bakhshinejad; Majid Sadeghizadeh; Sadegh Babashah
Journal:  Mol Biol Rep       Date:  2017-07-27       Impact factor: 2.316

4.  Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer.

Authors:  K Ichiki; N Mitani; Y Doki; H Hara; T Misaki; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 5.  Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.

Authors:  Ross L Pearlman; Mary Katherine Montes de Oca; Harish Chandra Pal; Farrukh Afaq
Journal:  Cancer Lett       Date:  2017-01-25       Impact factor: 8.679

6.  Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells.

Authors:  Tatsuro Watanabe; Hiromi Kuramochi; Atsushi Takahashi; Kazue Imai; Naoko Katsuta; Tomonobu Nakayama; Hirota Fujiki; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2012-05       Impact factor: 4.553

7.  Curcumin treatment alters ERK-1/2 signaling in vitro and inhibits nasopharyngeal carcinoma proliferation in mouse xenografts.

Authors:  Yi-Qiang Xie; Xian-Bo Wu; Song-Qi Tang
Journal:  Int J Clin Exp Med       Date:  2014-01-15

Review 8.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

Review 9.  Emerging phytochemicals for prevention of melanoma invasion.

Authors:  Virginia Jones; Santosh K Katiyar
Journal:  Cancer Lett       Date:  2013-03-06       Impact factor: 8.679

10.  Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-κB activation.

Authors:  Victor Fattori; Felipe A Pinho-Ribeiro; Sergio M Borghi; José C Alves-Filho; Thiago M Cunha; Fernando Q Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflamm Res       Date:  2015-10-11       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.